Antimicrobial Lock Therapy in Clinical Practice: A Scoping Review Protocol.
ALT
anti-infective agents
antimicrobial lock therapy
bacteremia
biofilm
catheter-related bloodstream infection
central venous catheters
central-line-associated bloodstream infection
scoping review
Journal
Methods and protocols
ISSN: 2409-9279
Titre abrégé: Methods Protoc
Pays: Switzerland
ID NLM: 101720073
Informations de publication
Date de publication:
12 Feb 2020
12 Feb 2020
Historique:
received:
19
12
2019
revised:
07
02
2020
accepted:
10
02
2020
entrez:
16
2
2020
pubmed:
16
2
2020
medline:
16
2
2020
Statut:
epublish
Résumé
Our objective is to review the scientific literature on the use of antimicrobial lock therapy (ALT). To achieve this result, our scoping review will address the following seven key questions: 1) Who are the patients who will benefit from this technique? 2) What are the techniques utilized? 3) What are the settings in which the technique is performed? 4) When the technique is performed? 5) Why the technique is performed? 6) How the technique is performed? 7) In how much amount, of such technique performed? This review considers all studies published in full and in peer-reviewed journals, with no restrictions on language, on the year of publication and age of the participants. Both randomized controlled trials and observational studies will be included. This scoping review has been planned on a five-stage framework: 1. Identifying the review question; 2. identifying relevant studies; 3. study selection; 4. charting the data; 5. collating, summarizing, and reporting the results. It is conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Guidelines. The databases utilized will include MEDLINE via PubMed, EMBASE and Cochrane Central Register of Controlled Trials and Grey Literature. SCOPING REVIEW REGISTRATION: Open Science Framework https://osf.io/vphwm/.
Identifiants
pubmed: 32059575
pii: mps3010016
doi: 10.3390/mps3010016
pmc: PMC7189672
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
All review authors disclose any potential conflict of interest, including any personal, financial, professional or intellectual bias.
Références
Infect Control Hosp Epidemiol. 2014 Jul;35(7):753-71
pubmed: 24915204
PLoS One. 2019 Feb 19;14(2):e0212426
pubmed: 30779771
Clin Infect Dis. 2012 Aug;55(3):364-70
pubmed: 22539665
Clin Infect Dis. 2008 Jul 1;47(1):83-93
pubmed: 18498236
J Clin Oncol. 2013 Apr 1;31(10):1357-70
pubmed: 23460705
Ann Intern Med. 2008 Apr 15;148(8):596-605
pubmed: 18413621
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Clin Infect Dis. 2009 Jul 1;49(1):1-45
pubmed: 19489710
J Thromb Haemost. 2014 Jun;12(6):847-54
pubmed: 24612469
Am J Infect Control. 2016 Dec 1;44(12):1495-1504
pubmed: 27742143
Cochrane Database Syst Rev. 2018 Apr 03;4:CD010597
pubmed: 29611180
Am J Health Syst Pharm. 2018 Mar 1;75(5):299-303
pubmed: 29472511
Nurs Res Pract. 2015;2015:985686
pubmed: 26075094
Health Info Libr J. 2009 Jun;26(2):91-108
pubmed: 19490148
J Emerg Med. 2016 Sep;51(3):252-8
pubmed: 27397766
N Engl J Med. 2015 Sep 24;373(13):1220-9
pubmed: 26398070
JAMA Intern Med. 2013 Dec 9-23;173(22):2039-46
pubmed: 23999949
Clin Infect Dis. 2014 Dec 15;59(12):1741-9
pubmed: 25156111
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Int J Infect Dis. 2019 Oct;87:154-165
pubmed: 31442627
Ann Oncol. 2015 Sep;26 Suppl 5:v152-68
pubmed: 26314776
Infection. 2015 Aug;43(4):389-98
pubmed: 25657033
Int J Antimicrob Agents. 2017 Sep;50(3):308-317
pubmed: 28689878
Clin Infect Dis. 2011 May;52(9):e162-93
pubmed: 21460264